Company intelligence / Profile preview

Molecular Decisions

Stanford, California, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~5
Development stage: Commercial

Overview

Molecular Decisions is a Stanford University spin-off developing innovative diagnostic solutions that enable nanoscale measurements of proteins and their phosphorylation states. Their technology aims to accelerate drug development, improve selection of cancer treatments, and provide rapid efficacy monitoring. The platform supports immediate clinical decision-making in oncology by enabling more efficient drug development and personalized treatment selection

Therapeutic areas: Oncology
Modalities: DeviceDiagnostic assay
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Molecular Decisions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molecular Decisions.

Explore the full profile